News › Industry News, News

Crown Laboratories Now Operates Under the Name Revance

May 2, 2025

Crown Laboratories, Inc. has announced that it will operate under the name Revance, a name that best represents the newly combined company mission to revolutionize the aesthetics and skincare industry through science-based, innovative products.

This change marks a significant milestone in the company’s strategic transformation following its recent acquisition of Revance Therapeutics, Inc., a biotechnology company known for its cutting-edge innovation in aesthetics and therapeutics, which joins Crown’s deep roots in science-driven brands for skin health and rejuvenation.

About Revance
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare offerings throughout every stage of life. With a differentiated portfolio of products spanning 60 countries, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and commercialization of new products and treatments.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics